![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
Acquired carbapenemase-producing organisms |
Thursday 9th February 2023 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]()
|
![]() |
Hospital and community laboratories are requested to refer all isolates of possible carbapenemase-producing organisms to ESR for confirmation and further characterisation. This includes all carbapenemase-producing Enterobacterales (CPE), carbapenemase-producing Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter. CPE surveillance reports are available. The first report covers the 6-year period 2009 (when the first CPE was identified in New Zealand) to 2014. Annual CPE surveillance reports are available for 2015 to 2021. In addition, until the annual surveillance report for the year is available, a cumulative line listing of carbapenemase-producing organisms confirmed during the year, updated at the end of each month, is available as an Excel file.
|
![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |